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Abstract 
The purpose of this research is to screen and identify the potential inducers in 
maximizing the production of monoclonal antibody by hybridoma 192 cell line 
for Congenital Adrenal Hyperplasia diagnostic. There are nine inducers used in 
this research, namely lysozyme, aldolase, sodium butyrate, sodium phosphate, 
potassium phosphate, dimethyl sulfoxide, lipopolysaccharide, essential amino 
acids, and nonessential amino acids. Hybridoma 192 cell was cultured in 5% 
CO2 incubator at 37°C and ˃80% humidity in the medium with different 
concentrations of inducer agents. The inducers were added at the beginning of 
the culture and the samples were taken after 72 h of culture. The performance of 
these inducer agents was assessed based on the maximum monoclonal antibody 
titer achieved using Enzyme-linked Immunosorbent Assay. Lipopolysaccharide 
was found to increase the maximum monoclonal antibody titer when 
supplemented at 8 to 12 µg/mL. After optimization using one-factor central 
composite design at this range, the optimum point was determined to be 8 
µg/mL. Verification experiments shows that lipopolysaccharide enhanced the 
average specific monoclonal antibody production rate by 56% relative to 
control. In conclusion, lipopolysaccharide at 8 µg/mL is able to increase the 
monoclonal antibody specific production of hybridoma 192 cell line. 
Keywords: Lipopolysaccharide, Inducer agent, Monoclonal antibody, Hybridoma, 
Congenital adrenal hyperplasia. 
 
 
1. Introduction 
Adrenal glands of people with Congenital Adrenal Hyperplasia (CAH) are unable 
to produce enough amounts of cortisol and aldosterone hormones due to defective 
genes that regulate the production of enzymes which involve in adrenal 
steroidogenesis [1]. Thus, it impairs the synthesis of cortisol and aldosterone. The 
most common type of CAH is due to the deficiency of 21-hydroxylase, which 
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Abbreviations 
17-OHP  17-hydroxyprogesterone 
ABTS 2,2’-azino-bis(3-ethylbenzythiazoline-6-sulfonic acid) 
CAH Congenital Adrenal Hyperplasia 
CHO Chinese hamster ovary 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO  dimethyl sulfoxide 
EAA essential amino acids 
ELISA enzyme-linked immunosorbent assay 
Gly glycine 
LPS lipopolysaccharide 
Lys lysine 
MAb monoclonal antibody 
NEAA nonessential amino acids 
most common type of CAH is due to the deficiency of 21-hydroxylase, which 
accounts for 95% of the cases. This type of CAH can be detected by the presence 
of high levels of 17-hydroxyprogesterone (17-OHP) in the serum [2,3]. 21-
Hydroxylase deficiencies can be divided into classic and nonclassic CAH. Classic 
CAH is usually found in the stage of infancy and early childhood. It can be 
considered as the most severe type of CAH. Early screening is a must because 
classic CAH is life threatening. Nonclassic CAH, on the other hand, manifests 
during or after puberty. Though it is not life threatening, nonclassic CAH can 
cause accelerated bone maturation and results in a reduced final height [4]. As the 
prevalence of classic CAH is very high at about 1:15,000 [5], a quick and reliable 
screening method for newborns is necessary. 
Current newborns screening methods for CAH include radioimmunoassay, 
time-resolved fluorescence spectroscopy, tandem mass spectrometry, DNA 
analysis, gas chromatography tandem mass spectrometry, high-performance liquid 
chromatography tandem mass spectrometry, and enzyme-link immunosorbent assay 
(ELISA) [4,6-8]. In hospitals, the most suitable assay to be used is ELISA method. 
It is sensitive, specific, fast, accurate, and cost effective. However, most of the 
current ELISA methods are based on the polyclonal antibody for diagnosis of CAH. 
Polyclonal antibody is not as specific as the monoclonal antibody (MAb), thus may 
give a higher frequency of false positive results. In view of this, Chong et al. [3] has 
developed an in-house mouse-mouse hybridoma (hybridoma 192), which produces 
the monoclonal antibody that recognizes 17-OHP with high specificity and 
sensitivity [3,9]. Even though there is one commercial monoclonal antibody 
recognizing 17-OHP available in the market, the cost per test kit is rather high. 
Thus, Chua [9] has attempted to optimize the medium used to culture hybridoma 
192 and successfully reduced the medium cost up to 65%. 
In order to produce antibodies specific for human antigens, the cell from mouse 
or rat is always the production source [10]. Similarly, hybridoma 192 cell line that 
produces MAb recognizing 17-OHP is also originated from a mouse. However, 
mouse-mouse hybridomas usually produce a low level of MAbs [11]. This means 
that, to produce sufficient amount of MAb for clinical trials, or commercial use, it 
will require the handling of multiple and/or huge volume cultures, which is not 
feasible in terms of time and cost. Hence, a technique to improve the production 
shall be sought. Enhancing the immunoglobulin or MAb production can be done in 
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many ways, for example, by modification of media supplements in the culture 
media [12], temperature control [13], or a combination of several factors including 
cell density and the duration of the culture [14]. Among these three ways of 
enhancing MAb productivity, modification of media supplements is the most 
suitable method for lab scale production. Temperature control and cell density 
control, on the other hand, are suitable for the production in a reactor. One type of 
culture media modifications is by adding inducer into the cell culture either at the 
beginning or at any appropriate time during the culture. A few researchers have 
shown that inducers such as amino acids [15,16], sodium phosphate [11], sodium 
butyrate [17], potassium phosphate [11], dimethyl sulfoxide (DMSO) [18-19],
 
lipopolysaccharide (LPS) [20,21], aldolase [22], and lysozyme [12,23] were 
effective in inducing the production of antibodies.  Therefore, the purpose of this 
research is to identify the most effective inducer that potentially maximizes the 
production of monoclonal antibody by hybridoma 192 cell line. 
2. Materials and Methods 
2.1. Materials and cell line 
Mouse hybridoma 192 cell line was a gift from Universiti Malaya. All chemicals 
were obtained from Sigma-Aldrich, USA, except fetal bovine serum that was 
bought from Gibco, Life Technologies, USA. ABTS [2,2’-azino-bis(3-
ethylbenzythiazoline-6-sulfonic acid)] buffer was purchased from Roche 
Diagnostics, Switzerland. 
2.2. Screening of potential inducer agent 
The nine selected components [essential amino acids (EAA), non-essential amino 
acids (NEAA), sodium butyrate, sodium phosphate, potassium phosphate, aldolase, 
lysozyme, DMSO, and LPS] were screened for their effectiveness in inducing the 
production of MAb. The concentration range studied is depicted in Table 1. In this 
study, cells inoculum with a viability of greater than 90% was centrifuged and 
inoculated at the cell density of 2  105 cells/mL into the test medium. The test 
medium was consisted of high glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM), fortified with 0.4% fetal bovine serum, 4 mM of L-glutamine, 312 M of 
ferric citrate, 4.5 M of zinc sulfate, and 17 nM of sodium selenite [9] and added with 
the specified amount of inducers tested. The experiments were run in the 6-wellplate 
(TPP, Switzerland) in triplicate. A control experiment (medium without inducer) was 
run together for each inducer. All cultures were kept in a humidified CO2 incubator 
(Shel Lab, Cornelius, USA) with 5% of CO2 at 37°C and greater than 80% humidity. 
Samples were harvested at 72 h, spun (500g, 10 min; Eppendorf Centrifuge 5415 R, 
Germany) and the supernatant was kept at -20°C until further analysis. The MAb titer 
attained at the time of harvest was monitored as the only response. 
2.3. Optimization and validation of effective inducer 
Based on the screening experiments with nine inducers (see Section 3.1), only 
LPS was selected for the further detailed study. The optimum concentration of 
LPS was determined using the response surface methodology approach. One 
factor central composite experimental design was chosen and the experiment was 
designed using Design Expert version 7.0. The LPS concentration range chosen 
for optimization was based on the results of screening (8-12 µg/mL). There was a 
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total of seven runs. The MAb titer attained at 72 h and the average specific MAb 
production rate were the responses monitored throughout the experiment. Data 
obtained from duplicate independent runs were used for the analysis (average of 
six measurements). Similar to the screening process, 2  105 cells/mL were spun 
and resuspended in the test medium with different concentrations of LPS. T-25 
flasks were used with a total volume of 10 mL. All cultures were kept in 
humidified CO2 incubator with 5% of CO2 at 37°C. The sampling was done at 24 
h intervals. Cell count was done immediately after the sampling and the 
supernatant was kept at −20°C until further analysis. The verification run was 
analogous to the optimization process experiments. LPS concentration used was 
according to the optimum point suggested by the software. The experiment was 
run in duplicate and the sampling was done at 24 h intervals for both cell density 
and MAb titer analysis. Data reported were the average of six measurements. 
Table 1. Concentration range of each inducer studied. 
Component Concentration range studied 
Sodium Butyrate 0-5 mM 
Sodium Phosphate 0-25 mM 
Potassium Phosphate 0-25 mM 
Aldolase 300-550 µg/ml 
Lysozyme 0-500 µg/ml 
LPS 0-25 g/ml 
Essential Amino Acids 0-5% (v/v) 
Non Essential Amino Acids 0-5% (v/v) 
DMSO 0-5% (v/v) 
2.4. Cell density determination 
Cell count was done by using hemocytometer. Trypan blue dye was used to 
differentiate between dead cells and living cells. Percentage viability was 
determined from the ratio of living cells to total cells calculated. 
2.5. MAb titer determination 
The concentration of total MAb was determined using the standard sandwich 
enzyme linked immunosorbent assay (ELISA) as described by Chong et al. [3]. 
All analyses were run in triplicate. Briefly, 1 g/mL of anti-mouse IgG from goat 
in 0.1 M of coating buffer at pH 9.6 was coated on all wells of a 96-well plate 
(maxisorp; Nunc A/S, Roskilde, Denmark) and incubated for 2 h at 37°C. The 
plate was then manually washed for several times with the washing buffer and 
tapped to dry. A blocking solution containing 1% w/v of bovine serum albumin 
and 0.1% v/v of Tween 20 was used to treat the plate before it was incubated 
overnight at 4°C. The plate was then washed with the washing buffer as explained 
above. Serially diluted mouse IgG was used as the standard. The standard and the 
diluted samples were added to separate wells and incubated at 37°C for 1.5 h. The 
washing process was then repeated. Next, diluted anti-mouse IgG peroxidase 
from goat was added to each well and incubated for 1.5 h at 32°C. The washing 
process was repeated. ABTS [2,2’-azino-bis(3-ethylbenzythiazoline-6-sulfonic 
acid)] buffer prepared in accordance with the instructions accompanying the 
product was added to the wells. The plate was left to stand for 25 min at 35°C for 
optimum color development. The plate was then read at 405 nm using a 
microplate reader (Columbus, Tecan, Switzerland). 
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3. Results and Discussion 
3.1.  Screening of inducing agent 
In this experiment, nine inducing agents were screened to determine their effect 
on MAb production by mouse hybridoma 192 cell lines. They were selected based 
on the positive inducing effects reported in the literature. A different range was 
selected for each inducer based on the reported optimum concentration in the 
previous studies. In order to determine the effect of each inducer in this study, the 
other factors such as temperature, pH, or cell density were fixed. Hybridoma 192 
was cultured in the complete DMEM as described in the methodology section 
without any addition of inducer for each run as a control. The MAb titer reported 
was the average of triplicate runs, and the results plotted were the average value 
of six measurements. 
Figures 1(a) to (c) show that the presence of EAA, NEAA, and sodium 
butyrate in the medium did not produce any significant inducing effect on MAb 
production. In addition, the addition of aldolase, potassium phosphate, and 
lysozyme reduced the MAb production, as shown in Figs. 1(d) to (f). At the time 
of harvesting for the medium which contained lysozyme, the MAb titer was about 
60% of that in the control [Fig. 1(f)]. On the other hand, the addition of aldolase 
or potassium phosphate into the medium reduced the MAb production to only 
about 30% of their respective control. The results obtained in this study are in 
contrast to the earlier findings in relation to lysozyme [12, 23], amino acids [15, 
16], sodium butyrate [17], aldolase [22], and potassium phosphate [11]. 
By feeding amino acids solution, Gong et al. [16] were able to increase the 
MAb production of JJ-1 cells from 116 mg/L to 707 mg/L. A similar observation 
was reported by Ducommun et al. [15], where balanced feeding of amino acids 
and vitamins increased the specific IgA production of Zac 3 cells from 0.60 
pg/cell.h to 1.10 pg/cell.h. However, the addition of both essential and 
nonessential amino acids in this study did not enhance the MAb production. A 
possible reason is that the other researchers specially formulated the amino acids 
solution and fed according to the consumption requirements of the cells, but in 
this study, the general essential or nonessential amino acids solution (obtained 
from Gibco) was added at the beginning of the culture without considering the 
consumption by the cells. Franĕk et al. [24] reported that the addition of free 
amino acids [glycine (Gly)/lysine (Lys) mixture] did not enhance MAb 
production, but the addition of Gly-Lys-Gly tripeptide improved the production. 
Thus, the enhancing effect of amino acids is specific to the cells and highly 
dependent on the type of amino acids being fed and the time of feeding. Amino 
acids consumption profiles were not scrutinized in this study, hence, specially 
formulated amino acids feeding were not tested. Moreover, the requirement of 
specially formulated amino acids feeding has violated the intention of maximizing 
yield with minimal cost and time.  
Kantardjieff et al. [17] treated the Chinese hamster ovary (CHO) cells with 
2 mM of sodium butyrate at 37°C and then changed the culture temperature to 
33°C during log phase. The antibody secreted has raised up to 520 µg/mL after 
170 hours of fermentation. Sodium butyrate is able to induce antibody production 
because of its ability to modulate the transcription of gene by inhibiting histone 
deacetylase and thus induces histone hyperacetylation [25]. However, antibody 
production for this experiment did not increase with the addition of sodium 
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butyrate. This may be because of the culture time that was too short and the 
temperature was higher at 37°C. Hence, the production of MAb was low as the 
condition was not ideal for triggering the MAb production by the cell. Another 
possible reason might be due to different cell line that contributes to the dissimilar 
responses to sodium butyrate addition.  
 
Fig. 1. MAb titer at 72 h in media supplemented with various concentrations 
of (a) essential amino acids, (b) non-essential amino acids, (c) sodium 
butyrate, (d) potassium phosphate, (e) aldolase, and (f) lysozyme. 
Aldolase was found to give significant effect toward HB4C5 cell and helped 
to enhance IgM four times better than IgG [22]. Suguhara et al. [22] proved that at 
a concentration of more than 1000 µg/mL, aldolase enhanced the concentration of 
IgM. This was in contrary with the results obtained in this study. Figure 1(e) 
shows that the production of MAb was the highest in the control culture. Hence, 
aldolase did not enhance the MAb production in this study. This may be due to 
different in cell line used in this study as compared to Suguhara and co-workers 
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[22]. On top of this, aldolase might only enhance the production of IgM but not 
too significant for inducing the IgG production, the monoclonal antibody type 
produced in our study.  
The optimum concentration of potassium phosphate studied by Sato et al. [11] 
was 15 mM in the culture of hybridoma HB4C5. Sato and co-workers [11] used a 
cell density of 5 × 10
5
 cells/mL and the production of MAb was stimulated more 
than 2-fold. Potassium phosphate was more effective in enhancing the production 
when seeded with higher cell density. The results obtained in this study was not in 
line with the findings of Sato et al. [11] in which the cell density used was 2.0 × 10
5
 
cells/mL and the result shows that at 15 mM concentration, the MAb production 
was less than 50% of the production of MAb by control cells. The plausible 
explanation is that the addition of potassium phosphate has disturbed the Na
+
/K
+
 
balance which may have some complex effects on cellular metabolism [26]. This, in 
turn, affects the antibody production as cellular energy and nutrients have been 
concentrated to maintain the normal function of the cells. The effect is especially 
obvious at low cell density. Another possibility is the instability of MAb in the 
presence of potassium phosphate, which changes the conformational structure and 
makes it inactive [27]. Murakami et al. [23] found that 380 µg/mL of lysozyme 
stimulated the production of IgM up to 13-fold by HB4C5 hybridoma cells. The 
finding in this research, however, was that lysozyme at the range of 0-500 µg/mL 
had no stimulatory effect on MAb production by hybridoma 192 cells. Therefore, 
the effect of lysozyme might be cell specific. 
Ling et al. [19] reported that the productivity of their hybridoma culture 
increased 2-fold following the addition of 0.2% (v/v) of DMSO at the time of the 
maximal viable cell densities. A 3-fold increase in the productivity of hepatitis B 
surface antigen by CHO cells, when supplemented with 1.5% (v/v) of DMSO at 
96 h of culture, has been reported [18]. The present work studied the stimulating 
effect of DMSO in the concentration range of 0-5% (v/v). Two independent sets 
of experiments were run. The first duplicate set of experiments was run without 
spinning the cells prior to resuspending into the fresh test medium that contained 
0-2.5% (v/v) of DMSO. The results are depicted in Fig. 2(a). Due to the spent 
medium carry over in the inoculum, the real concentration of DMSO in the study 
was less than the values shown in Fig. 2(a). When the error was realized, the 
experiment was repeated with a broader concentration range of DMSO and the 
cells were spun prior to resuspending. The results of the repeated experiment were 
shown in Fig. 2(b). Figures 2(a) and (b) display a totally different behavior. There 
is a significant increase in MAb titer at the time of harvesting (i.e., 72 h) for the 
experiment with a low concentration of DMSO and spent medium carry over [Fig. 
2(a)]. In addition, MAb productivity was also found to increase in this 
experiment. Cells tend to lyse and growth is suppressed when DMSO is added to 
the culture as previously reported by others [18-19]. Lysed cells release the 
antibody that may not have fully formed into the culture [28]. However, in Fig. 
2(b) where the cells were spun and the concentration range of DMSO was 
broader, the MAb titer declined with increased concentration of DMSO. In fact, 
the MAb titer at the time of harvesting was very much lower in DMSO-containing 
media as compared to the control. Thus, the response of cells towards DMSO was 
inconsistent. This was in agreement with the findings of Allen et al. [29], who 
found that the effect of DMSO on the cells could only be seen at the concentration 
of above 1% (v/v), but this effect was not consistent. 
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Fig. 2. MAb titer at 72 h in media supplemented with various  
concentrations of DMSO (%v/v); (a) no spinning and (b) with spinning. 
Figure 3(a) shows that the production of IgG is the highest when the cell was 
treated with 25 mM of sodium phosphate. Compared to MAb produced in control 
media, the production increased about 2-fold. Sato et al. [11] identified 15 mM as 
the optimum concentration for MAb production by human-human hybridoma 
HB4C5. However, for hybridoma 192 cells, the production of MAb fluctuated 
when the concentration of sodium phosphate was increased as depicted in Fig. 
3(a). Thus, the results were considered not valid. 
 
Fig. 3. MAb titer at 72 h in media supplemented with  
various concentrations of (a) sodium phosphate and (b) LPS. 
As the stimulatory effect of DMSO and sodium phosphate could not be 
assured, while amino acids and sodium butyrate produced no benefit along with 
lysozyme, and aldolase and potassium phosphate had a negative effect, all these 
inducers were excluded from further study. 
Figure 3(b) shows the MAb titer attained at 72 h with the various 
concentrations of LPS in the medium. LPS concentration of 5-15 µg/mL shows a 
significant increase in MAb titer as compared to the control (without LPS). The 
stimulation effect of LPS seemed to be quite promising because the preliminary 
study using LPS at a similar concentration range also enhanced the MAb titer as 
compared to control. As a result, LPS was further optimized within the 
concentration range of 5-15 µg/mL. 
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3.2. Determination of optimum LPS concentration 
Table 2 illustrates the results of analysis of variance (ANOVA) for the optimization 
using central composite design. It reveals that the increasing LPS concentration will 
have a negative effect on the MAb titer and specific MAb production rate. In other 
words, the increase in LPS concentration would decrease the MAb titer attained and 
reduce the specific MAb production rate. The significant term in both models is the 
quadratic term of LPS concentration (A
2
). LPS concentration (A) is also significant 
in the average specific MAb production rate model. 
Table 2. Analysis of variance table for maximum MAb titer and average 
specific MAb production rate. 
Factors 
Maximum MAb titer 
Average specific MAb 
production rate 
Effect F-ratio p-value Effect F-ratio p-value 
A - LPS 
concentration 
−0.38 2.32 0.2020 −0.008 8.37 0.0444a 
A
2
 1.69 12.36 0.0246* 0.048 82.46 0.0008
a 
Lack of Fit - 0.49 0.6693 - 3.18 0.2391 
a
 Significant at p < 0.05 
The experimental results obtained were fitted to the quadratic model equations 
in coded form as follows: 
Maximum MAb titer = 6.25 − 0.38𝐴 + 1.69𝐴2              (1) 
Average Specific MAb production rate = 0.11 − 0.008𝐴 + 0.048𝐴2              (2) 
The goodness of fit (R
2
) and the goodness of prediction (Q
2
) are two parameters 
used to evaluate the models. R
2
 for average specific MAb production rate in this 
study is 0.9367, which is greater than 0.75, revealing that the model fits well. 
However, the model for the maximum MAb titer could only be considered as a fair 
model because the R
2
 is 0.6788, which is less than 0.75. As for the prediction 
power, the Q
2
 value for maximum MAb titer is 0.3215, while the Q
2
 value for 
average specific MAb production rate is 0.8791. The value well above 0.75 is 
considered as having a good prediction power, while it is considered fair if the Q
2
 
value is between 0.25 and 0.75. Therefore, the models are expected to be able to 
predict the optimum values reasonably well. Based on the models, the optimum 
point is predicted to be at an LPS concentration of 8 µg/mL. At this optimum point, 
the maximum MAb titer and the specific MAb production rate are predicted to be 
8.3 µg/mL and 0.16 pg/cell.h, respectively. This optimum point was verified by 
running a duplicate experiment at the predicted optimal LPS concentration of 
8 µg/mL. A control was also run in duplicate for comparison.  
3.3. Verification of the optimum point 
Table 3 compares the actual experimental values of the maximum MAb titer and the 
average specific MAb production rate with the predicted values from the model and 
the actual values of control run. It can be seen that the actual maximum MAb titer 
obtained is lower than the predicted and control values. This is obviously in contrast 
to the results obtained during screening and optimization processes. The reason 
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behind this is not clear and needs further investigation. Yet, Table 3 also reveals that 
the actual average specific MAb production rate obtained is very much higher than 
the predicted and control values. The increment of productivity is up to 56% (or 
1.6-fold) as compared to the control. The addition of LPS into the culture medium 
has a suppression effect on growth resembling that of DMSO [18-20]. However, 
LPS did not lyse the cells. Through microscopy observation during cell counting, 
LPS only suppressed the growth of cells for the first 24 to 48 hours (Fig. 4). Cell 
grew as usual afterward. This suppression effect reduced the cell number at the time 
of harvesting. The average specific MAb production rate was calculated based on 
the maximum MAb titer achieved using the viable cell density attained at the 
instance of maximum MAb titer, which led to the increase in the value of the 
average specific MAb production rate. 
Table 3. Comparison of the predicted, actual, and  
control values for maximum MAb titer and average specific 
MAb production rate in the verification experiments. 
Type of 
response 
Maximum 
MAb titer 
(µg/mL) 
Average specific MAb 
production rate 
(pg/cell.h) 
Predicted 8.3 0.16 
Actual* 6.2 ± 0.3 0.25 ± 0.02 
Control* 7.3 ± 0.8 0.16 ± 0.01 
     * Value at t = 72 hr 
 
Fig. 4. Growth profiles and MAb titer during verification runs. (Solid line = 
growth profile, dash line = MAb titer; ● = optimum point, ■ = control). 
Even though LPS would suppress growth, its influence was inconsistent. The 
suppression effect was not observed in the screening experiment, but was obviously 
seen in the optimization experiment and also in the verification run. This may be 
the reason that maximum MAb titers obtained were higher in the screening 
experiment, but not in the optimization experiment or the verification run. At the 
time of harvesting (i.e., 72 h), cells supplemented with LPS had just returned to 
their normal growth rate and the cell number was lower than the control culture 
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(Fig. 4). As a result, the MAb titer produced was also lower than the control culture 
that contained a higher cell number. If the culture was harvested at a later time, the 
maximum MAb titer achieved might have improved. LPS is believed to be able to 
stimulate the immune response of mammalian cells but suppresses growth [20,21]. 
Thus, this could be a plausible explanation for the enhancement of MAb production 
rate in this case. 
Martín-López et al. [20] found that the addition of 5 g/mL of LPS to the 
culture of 55-6 murine B cell hybridoma increased the MAb production rate by 2.5-
fold as compared to the control. In this study, the LPS concentration used was 8 
µg/mL, which was 1.5-fold greater than that used by Martín-López et al. [20]. 
Nevertheless, the enhancement of MAb production was only 1.6-fold. Different 
cells may differ in their responses to the LPS at different concentrations [21]. For 
example, Oliver et al. [21] observed that the ability of marginal zone B cells and 
follicular B cells to proliferate and differentiate into plasma cells depended on the 
LPS concentration. Furthermore, the difference in response to the LPS may also due 
to the medium used. Martín-López et al. [20] and Oliver et al. [21] used RPMI 1640 
supplemented with 10% serum, while DMEM supplemented with a minimal 
percentage of serum (0.4%) was used in this study. It is known that the undefined 
components in serum which include growth factor and antioxidant have the function 
of protecting the cells and promoting growth and production. Thus, this may be the 
reason for higher survival and production rates of the previous studies even though 
they were using lower cell density as compared to this study. 
4. Conclusions 
LPS at a concentration of 8 µg/mL was found to be suitable for stimulating the 
MAb production of hybridoma 192. The verification process confirmed that LPS 
enhanced the average specific MAb production rate by 1.6-fold relative to control, 
but not the maximum MAb titer. Even though an effective inducer was identified, 
but the level of enhancement of the average specific MAb production rate could not 
compensate for the high cost of the inducer. Thus, it is recommended to study a few 
other factors such as the effect of temperature or the time of addition in order to 
maximize the MAb production and counterbalance the high cost of inducer. 
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